BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• 

  Career Advice

  6 Easy Resume Updates You Should Make ASAP

  Whether or not you’re actively looking for a new job, it’s always prudent to regularly do a resume update, refresh, and in general keep optimizing your resume.

  May 9, 2018

   · 

  2 min read
• 

  Deals

  Are Older Billionaires Funding Biotechs Focused on Longevity?

  It has been noted that a number of billionaires—at least six—who are fifty years or older in age, have been investing in health care and longevity-related startup companies.

  May 9, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  AIDS Healthcare Foundation Files Additional Lawsuits Against Gilead over TDF Toxicity Concerns

  Gilead Sciences is facing another round of lawsuits regarding its HIV treatments. This morning the AIDS Healthcare Foundation announced two sets of California-based patients filed a personal injury lawsuit against the Bay Area company regarding safety concerns surrounding its TDF treatment.

  May 9, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Company that Develops High-Quality Prescription Medical Video Games, Akili Interactive, Raises $55M

  Akili Interactive, headquartered in Boston, closed a $55 million Series C financing. Akili is a prescription digital medicine company. Its goal is to treat certain disorders via high-quality video games.

  May 9, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Lodo Therapeutics and Genentech Ink Strategic Collaboration Potentially Worth $1 Billion or More

  Lodo Therapeutics, based in New York, formed a strategic drug discovery collaboration with Genentech, a Roche company, in a deal potentially worth more than $1 billion.

  May 9, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Regeneron Talent Search Doles Out $1.8 Million in Awards to High School Scientists

  Training the next generation of scientists is a key for the future of the biotech industry and Regeneron Pharmaceuticals is taking a lead in that responsibility through its sponsorship of the Regeneron Science Talent Search.

  May 9, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Oncolytic Viruses: Huge Potential for Immuno-Oncology

  The uses of viruses as therapeutics is growing, largely because new gene therapy treatments require viruses.

  May 9, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  UPDATED: Novartis Reveals it Paid President Trump’s Attorney $1.2 Million for Healthcare Consulting Services

  Novartis paid far more than $400,000 to President Donald Trump’s lawyer Michael Cohen -- $800,000 more, the company revealed in a statement issued late Wednesday.

  May 9, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Escient Pharmaceuticals Launches with $40 Million

  Escient Pharmaceuticals launched in San Diego with a Series A financing round worth $40 million. The round was syndicated by The Column Group and 5AM Ventures, and joined by Osage University Partners.

  May 9, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  4 Big Pharma Biotech Accelerators: Investing in Innovation

  Some accelerators come out of government and academic institutions, while others have specific big pharma backing. Many use a combination of all of the above, while some are private in nature linked to venture capital firms. Let’s look at some of the accelerators linked to big pharma.

  May 9, 2018

   · 

  3 min read

   · 

  Mark Terry